Skip to Content

Accuray Inc ARAY

Morningstar Rating
$1.90 −0.04 (2.06%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ARAY is trading at a 412% premium.
Price
$1.94
Fair Value
$5.44
Uncertainty
Very High
1-Star Price
$5.65
5-Star Price
$1.93
Economic Moat
Yqt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ARAY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.94
Day Range
$1.881.95
52-Week Range
$1.474.27
Bid/Ask
$1.90 / $1.91
Market Cap
$188.56 Mil
Volume/Avg
32,281 / 685,216

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.44
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
1,024

Comparables

Valuation

Metric
ARAY
ATEC
NYKD
Price/Earnings (Normalized)
Price/Book Value
4.7143.542.77
Price/Sales
0.442.9640.00
Price/Cash Flow
116.77
Price/Earnings
ARAY
ATEC
NYKD

Financial Strength

Metric
ARAY
ATEC
NYKD
Quick Ratio
0.701.378.43
Current Ratio
1.582.398.43
Interest Coverage
−0.51−9.60
Quick Ratio
ARAY
ATEC
NYKD

Profitability

Metric
ARAY
ATEC
NYKD
Return on Assets (Normalized)
−2.00%−9.36%−18.26%
Return on Equity (Normalized)
−19.12%−23.64%
Return on Invested Capital (Normalized)
−0.09%−9.08%−26.98%
Return on Assets
ARAY
ATEC
NYKD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
XnqlhjtrPvslhh$182.1 Bil
Stryker Corp
SYK
TcsvqjlytQtq$127.5 Bil
Boston Scientific Corp
BSX
TtxnfwpgwZghkzy$113.8 Bil
Medtronic PLC
MDT
JjvrzycSrzgvcx$104.2 Bil
Edwards Lifesciences Corp
EW
SxgsjrfbslPswgx$52.6 Bil
DexCom Inc
DXCM
KtbqxxwpQlcz$45.4 Bil
Koninklijke Philips NV ADR
PHG
DzzpmttqfPpqck$24.2 Bil
Zimmer Biomet Holdings Inc
ZBH
JrxslvqgZwd$22.8 Bil
Steris PLC
STE
QgcmxbxcHvbpzc$22.6 Bil
Align Technology Inc
ALGN
PvdmchbRvfltfg$18.9 Bil

Sponsor Center